A detailed history of Comerica Bank transactions in Atri Cure, Inc. stock. As of the latest transaction made, Comerica Bank holds 484 shares of ATRC stock, worth $17,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares
484
Previous 1,666 70.95%
Holding current value
$17,937
Previous $37,000 64.86%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$20.34 - $29.5 $24,041 - $34,869
-1,182 Reduced 70.95%
484 $13,000
Q2 2024

Aug 15, 2024

SELL
$19.86 - $29.09 $17,000 - $24,901
-856 Reduced 33.94%
1,666 $37,000
Q1 2024

May 15, 2024

BUY
$28.21 - $37.78 $29,423 - $39,404
1,043 Added 70.52%
2,522 $76,000
Q4 2023

Feb 14, 2024

SELL
$32.99 - $43.25 $32,759 - $42,947
-993 Reduced 40.17%
1,479 $52,000
Q3 2023

Nov 21, 2023

SELL
$41.12 - $57.73 $560,342 - $786,686
-13,627 Reduced 84.65%
2,472 $108,000
Q2 2023

Aug 22, 2023

BUY
$40.44 - $49.6 $651,043 - $798,510
16,099 New
16,099 $96,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.72B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.